Founders and Team
Univ.-Prof. Dr. Ursula Schmidt-Erfurth
SCIENTIFIC AND MEDICAL ADVISOR & FOUNDER
As Co-founder and Member of the Advisory Board, Prof. Schmidt-Erfurth represents independent scientific and medical expertise and is one of the world’s leading specialists in the field of retina. She is Professor and Chair of the Department of Ophthalmology at the Medical University of Vienna, Adjunct Professor of Ophthalmology at Northwestern University and a Full Member of the Austrian Academy of Sciences.
She is Founder & Director of the VRC (Vienna Reading Center), a digital platform for image analyses connected to 800 clinical centers world-wide. She serves as the medical director of the Christian Doppler Laboratory for ophthalmic image analysis (OPTIMA), pioneering AI in diagnostic and therapeutic ophthalmology and is holding several patents in imaging and AI. She has published over 450 papers in the world’s leading ophthalmological journals.
RetInSight and the Medical University are partners under a collaboration agreement.
Hans Peter Schwarz, MD, Associate Professor of Medicine
MANAGING PARTNER, CFO & FOUNDER
Prof. Schwarz, a physician by training, is an accomplished healthcare executive with more than 30 years experience in the biopharmaceutical and device industry. Prior to joining RetInSight Dr. Schwarz held leadership roles with Baxter, Baxalta and Shire and served as a Member of the Board of Baxter AG in Vienna, the Management Board of the Baxter/Baxalta Austria Corporation, an operation with approx. 4300 employees in Austria.
In his role as Global VP Research and Development of Baxter BioScience, Dr. Schwarz was responsible for developing a strong product pipeline for Baxter BioScience bringing successfully biological products from discovery to global regulatory approval. Dr. Schwarz is managing partner and CFO of RetInSight.
Dr.-Ing. Amir Sadeghipour
CHIEF TECHNOLOGY OFFICER & FOUNDER
Amir Sadeghipour completed his studies in computer science at the TU Berlin with a focus on ArtificiaI Intelligence and was awarded the “Best Doctoral Dissertation of 2015” at the Technical Faculty of Bielefeld University.
He has over 13 years of experience in research and development of AI methods and 6 years of working experience in the private sector. Amir led the software development at OPTIMA (Medical University of Vienna) for over 4 years, developing software and AI algorithms for ophthalmic image analyses. In addition, he served as the Head of IT at the VRC (Vienna Reading Center). He represents RetInSight’s technical-scientific competence as Chief Technology Officer responsible for AI research and development.
Corinna zur Bonsen-Thomas
MANAGING PARTNER, CEO & FOUNDER
Corinna zur Bonsen-Thomas, RetInSight’s managing partner and CEO, is a legal executive with 30 years of experience in senior roles in the global pharmaceutical and medical device industry.
Since 2017 she has been an advisor and General Counsel for small businesses and start-ups focusing on medical software and digital image analysis (including Definiens AG; Smart Reporting GmbH). Corinna is a member of the supervisory board of Abivax, a French listed biotech company.
HEAD OF QUALITY MANAGEMENT & REGULATORY AFFAIRS
Thomas Grundnig has over 20 years of experience with Quality Management and Regulatory Affairs in the medical industry. He has extensive expertise with medical device development, production, and commercialization.
In particular, he is an expert in medical device certification according to previous and current EU regulations, which include technical documentation compliance, software development lifecycle requirements, risk management, usability, post-market surveillance, and post-market clinical follow-up. Thomas acts as Head of Quality Management and Regulatory Affairs.
Martina Neschi, PhD
PHARMA ALLIANCE MANAGER
Martina Neschi gained her PhD in Biomedicine and Biotechnology granted by the DOC-fFORTE Scholarship of The Austrian Academy of Sciences.
After dedicating several years to basic research, she joined the Department of Ophthalmology at MUV where she focused on study coordination of investigator-initiated studies and sponsor-initiated trials. In this capacity, she worked closely with pharmaceutical partners, ethic committees, federal agencies, ophthalmologists and physicians of complementary discipline, and image grading experts. At RetInSight, Martina assumes her role as project manager and pharma alliance manager.
Isabel Goppelt, PhD, PMP
HEAD OF PROJECT MANAGEMENT
Isabel Goppelt, a biochemist and PMP-certified project manager, has more than 15 years of experience at scientific institutes (Max-Planck Society) and within the international pharmaceutical industry (GlaxoSmithKline, UK and Baxter, Austria).
Initially leading research projects in the area of neuroscience, Isabel later broadened her scientific area of expertise to include other therapeutics indications. She also has extensive knowledge in commercial aspects of the business, including alliance management, project and portfolio management and change management. At RetInSight, Isabel is responsible for HR and Project Management.
- Univ.-Prof. Dr. Ursula Schmidt-Erfurth
Professor and Chair, Medical University Vienna, Department of Ophthalmology and Optometry
- Univ.-Prof. Dr. Sepp Hochreiter
Director, Institute for Machine Learning, Johannes Kepler University Linz, Austria
- Prof. Dr.med. Dr.h.c. Ralf Huss
Director, Institute for Digital Medicine, Medical Faculty University Augsburg, Germany
- Dr. Wolfgang Hackel
CFO Global R&D, Takeda